Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Benedikt Kowalski"'
Autor:
Pascal Bezel, Maya Vonow-Eisenring, Dieter Scholtze, Benedikt Kowalski, Andrea Widmer, Stephan Wieser, Malcolm Kohler, Alan Valaperti, Urs C. Steiner, Daniel Franzen
Purpose Immune-checkpoint inhibitors (ICI) present a new treatment for malignancies by boosting the immune system. This has led to a variety of immune-related adverse events, including ICI-associated pneumonitis (ICIaP). Diagnosis thereof is often ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe1b6cd73dfc8727e4a884548b6704b2
https://doi.org/10.5167/uzh-209477
https://doi.org/10.5167/uzh-209477
Publikováno v:
Die Unfallchirurgie. 125:580-582
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56c206b693a8141a4b18a0130912bbee
https://doi.org/10.1007/s00113-021-01064-w
https://doi.org/10.1007/s00113-021-01064-w
Publikováno v:
Unfallchirurgie (Heidelberg, Germany)Literatur. 125(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fd8cf69e9047a23585ec5167391aa21
https://pubmed.ncbi.nlm.nih.gov/34324035
https://pubmed.ncbi.nlm.nih.gov/34324035
Autor:
Dieter Scholtze, Alan Valaperti, Pascal Bezel, Stephan Wieser, Malcolm Kohler, Andrea Widmer, Urs C. Steiner, Daniel Franzen, Maya Vonow-Eisenring, Benedikt Kowalski
BackgroundImmune-checkpoint inhibitors (ICI) present a new treatment for malignancies by boosting the immune system. This has led to a variety of immune-related adverse events, including ICI-associated pneumonitis (ICIaP). Diagnosis thereof is often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d866176f032e11b98e60014a82ce392
https://doi.org/10.21203/rs.3.rs-129954/v1
https://doi.org/10.21203/rs.3.rs-129954/v1
Autor:
Marco P. Zalunardo, Claudio Caviezel, Daniel Franzen, Benedikt Kowalski, Hülya Begdeda, Bastian Grande
Publikováno v:
J Thorac Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f734345f6e8249461249051fa496608d
https://pubmed.ncbi.nlm.nih.gov/33209446
https://pubmed.ncbi.nlm.nih.gov/33209446
Autor:
Andrea Widmer, Pascal Bezel, Stephan Wieser, Malcolm Kohler, Dieter Scholtze, Maya Vonow-Eisenring, Alan Valaperti, Benedikt Kowalski, Urs C. Steiner, Daniel Franzen
Publikováno v:
Cancer Immunology, Immunotherapy
Introduction Lung cancer is the leading cause of death by cancer. In recent years, immunotherapy with checkpoint inhibitors (ICI) emerged as a promising new therapeutic approach. However, a deeper understanding of the immunologic responses adjacent t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae337106fd4e1e3f2d503fb9c4337021
https://pubmed.ncbi.nlm.nih.gov/33394095
https://pubmed.ncbi.nlm.nih.gov/33394095
Autor:
Benedikt Kowalski, Reinhard Dummer, Christian F. Clarenbach, Daniel Franzen, Karin Schad, Roger Stupp, Malcolm Kohler
Ipilimumab, an immune checkpoint inhibitor, is approved for treatment metastastic melanoma and is a promising agent against other malignancies. There is some preliminary evidence from case reports that ipilimumab treatment may be associated with pulm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa5dd020d9a76826b68c68e8269d89f
https://www.zora.uzh.ch/id/eprint/142644/
https://www.zora.uzh.ch/id/eprint/142644/